BDBM5039 N-(5-tert-Butyl-3,4-dimethyl-1,3-thiazol-2(3H)-ylidene)-5-chloro-2-nitrobenzenesulfonamide::N-[(2Z)-5-tert-butyl-3,4-dimethyl-2,3-dihydro-1,3-thiazol-2-ylidene]-5-chloro-2-nitrobenzene-1-sulfonamide::thiazolidenebenzenesulfonamide deriv. 10i
SMILES Cc1c(s\c(=N/S(=O)(=O)c2cc(Cl)ccc2[N+]([O-])=O)n1C)C(C)(C)C
InChI Key InChIKey=SLVTZQNLJHWHMX-VKAVYKQESA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 5039
TargetGag-Pol polyprotein [588-1027,K690N]/[588-1147,K690N](Human immunodeficiency virus type 1)
Yamanouchi Pharmaceutical
Yamanouchi Pharmaceutical
Affinity DataIC50: >5.00E+4nMAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [588-1027]/[588-1147](Human immunodeficiency virus type 1)
Yamanouchi Pharmaceutical
Yamanouchi Pharmaceutical
Affinity DataIC50: 2.40E+3nMAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair